These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6504178)

  • 21. Translational therapeutics at the platelet vascular interface. Summary.
    FitzGerald GA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments against aggregation inhibitors].
    Reuter HD
    Internist (Berl); 1980 Jul; 21(7):390-2. PubMed ID: 7007277
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
    Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
    [No Abstract]   [Full Text] [Related]  

  • 24. [Non-steroid inflammatory drugs in the prevention of myocardial infarction].
    Basista M; Kostka-Trabka E
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1645-8. PubMed ID: 6382207
    [No Abstract]   [Full Text] [Related]  

  • 25. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
    Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin for the primary prevention of coronary events.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12240692
    [No Abstract]   [Full Text] [Related]  

  • 27. Pravastatin and coronary heart disease.
    Bloom JM
    N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract]   [Full Text] [Related]  

  • 28. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM
    G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin and coronary artery diseases.
    Jauhari J
    J Indian Med Assoc; 1993 Mar; 91(3):50-1. PubMed ID: 8349998
    [No Abstract]   [Full Text] [Related]  

  • 30. [5-aminosalicylic acid and thrombocyte function].
    Schölmerich J
    Dtsch Med Wochenschr; 1995 May; 120(20):742. PubMed ID: 7758415
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
    Am J Cardiol; 2005 Oct; 96(8):1095-9. PubMed ID: 16214444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin and ischaemic heart disease.
    Br J Hosp Med; 1986 Aug; 36(2):85. PubMed ID: 3527318
    [No Abstract]   [Full Text] [Related]  

  • 34. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
    Vyshlov EV; Panfilova EV; Markov VA
    Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aspirin].
    Soejima H; Kishikawa H; Ogawa H
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():414-8. PubMed ID: 22519025
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Take an aspirin or have a drink: antecedent aspirin and moderate alcohol consumption similarly affect baseline platelet characteristics in patients with acute myocardial infarction.
    Serebruany VL; Lowry DR;
    Thromb Haemost; 2000 Nov; 84(5):933-4. PubMed ID: 11127889
    [No Abstract]   [Full Text] [Related]  

  • 40. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.